Back
Diebold Nixdorf, Inc. 10K Form
Buy
76
DBD
Diebold Nixdorf, Inc.
Last Price:
$64.89
Seasonality Move:
11.65%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive DBD News And Ratings
See the #1 stock for the next 7 days that we like better than DBD
DBD Financial Statistics
Sales & Book Value
| Annual Sales: | $3.8B |
|---|---|
| Cash Flow: | $24.5M |
| Price / Cash Flow: | 10.55 |
| Annual Sales: | $29.47 |
| Price / Book: | 2.1 |
Profitability
| EPS (TTM): | 1.36430 |
|---|---|
| Net Income (TTM): | $53.3M |
| Gross Margin: | $947.8M |
| Return on Equity: | 5.1% |
| Return on Assets: | 1.44% |
Diebold Nixdorf, Inc. Earnings Forecast
Key Diebold Nixdorf, Inc. Financial Ratios
-
The Gross Profit Margin over the past 45 years for DBD is 25.27%.
-
The Selling, General & Administrative Expenses for DBD have been equal to 17.16% of Gross Profit Margin.
-
The Research & Development expenses have been 2.37% of Revenue.
-
The Net Earning history of DBD is -0.39% of Total Revenues.
-
Per Share Earnings over the last 45 years have been positive in 21 years.
Diebold Nixdorf, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Technology Hardware, Storage & Peripherals |
| Sector: | Information Technology |
| Current Symbol: | DBD |
| CUSIP: | 253651 |
| Website: | dieboldnixdorf.com |
Debt
| Debt-to-Equity Ratio: | 0.96 |
|---|---|
| Current Ratio: | 1.36 |
| Quick Ratio: | 0.69 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 12.9 |
DBD Technical Analysis vs Fundamental Analysis
Buy
76
Diebold Nixdorf, Inc. (DBD)
is a Buy
Is Diebold Nixdorf, Inc. a Buy or a Sell?
-
Diebold Nixdorf, Inc. stock is rated a BuyThe current Diebold Nixdorf, Inc. [DBD] share price is $64.70. The Score for DBD is 76, which is 52% above its historic median score of 50, and infers lower risk than normal.